1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Investigator-Initiated Research Award – Funding Level 1 is sponsored by Congressionally Directed Medical Research Programs (CDMRP) Vision Research Program (VRP). Supports exploratory, high-risk and high-reward research in the earliest stages of development that has the potential to yield new avenues of investigation, approaches, research tools, or paradigms. Must address at least one of the VRP focus areas.
Get alerted about grants like this
Save a search for “Congressionally Directed Medical Research Programs (CDMRP) Vision Research Program (VRP)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: See program announcement for specific eligibility criteria, which may include researchers from academic institutions, private industry, and federal laboratories. Focus is often on military-relevant vision research. Confirm the full requirements in the official notice before applying.
The current listing shows up to $400,000 over 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Investigator-Initiated Research Award – Funding Level 1 are due June 28, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Investigator-Initiated Research Award – Funding Level 1 is funded by Congressionally Directed Medical Research Programs (CDMRP) Vision Research Program (VRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article